dofetilide
Also known as Tikosyn®, UK-68798, beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide, Dofetilidum, Dofetilida
Dofetilide is a class III antiarrhythmic agent. It is marketed under the trade name Tikosyn by Pfizer, and is available in the United States in capsules containing 125, 250, and 500 μg of dofetilide. It is not available in Europe or Australia.
~7 min read
Article
10 sectionsContents
- Medical uses
- Contraindications
- Adverse effects
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- Metabolism
- History
- See also
- References
{{Drugbox | verifiedrevid = 457790505 | IUPAC_name = N-[4-(2-{[2-(4-methane sulfonamidophenoxy)ethyl] (methyl)amino}ethyl)phenyl]methanesulfonamide | image = Dofetilide.svg | image_class = skin-invert-image
| tradename = Tikosyn | Drugs.com = | MedlinePlus = a601235 | pregnancy_category = | legal_status = | routes_of_administration =